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In Brief
Magri et al. found that the human gut
includes a large memory IgM+ B cell
repertoire clonally related to plasma cells
mounting SIgM responses against
mucus-embedded commensals co-
targeted by SIgA. Dually coated bacteria
are detected in humans but not mice and
show increased diversity and richness
compared to SIgA-only-coated or
uncoated bacteria.
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Secretory immunoglobulin A (SIgA) enhances host-
microbiota symbiosis, whereas SIgM remains poorly
understood. We found that gut IgM+ plasma cells
(PCs) were more abundant in humans than mice
and clonally related to a large repertoire of memory
IgM+ B cells disseminated throughout the intestine
but rare in systemic lymphoid organs. In addition to
sharing a gut-specific gene signature with memory
IgA+ B cells, memory IgM+ B cells were related to
some IgA+ clonotypes and switched to IgA in
response to T cell-independent or T cell-dependent
signals. These signals induced abundant IgM which,
together with SIgM from clonally affiliated PCs,
recognized mucus-embedded commensals. Bacte-
ria recognized by human SIgM were dually coated
by SIgA and showed increased richness and diver-
sity compared to IgA-only-coated or uncoated bac-
teria. Thus, SIgM may emerge from pre-existing
memory rather than newly activated naive IgM+ B
cells and could help SIgA to anchor highly diverse
commensal communities to mucus.
INTRODUCTION
Complex commensal communities generally referred to as mi-
crobiota colonize the gut mucosa soon after birth and have a
broad impact on host metabolism, immune system develop-
ment, and gut homeostasis (Kamada et al., 2013). A central118 Immunity 47, 118–134, July 18, 2017 ª 2017 The Authors. Publis
This is an open access article under the CC BY-NC-ND license (http://element of gut homeostasis is secretory immunoglobulin A
(SIgA), an antibody that promotes symbiotic host-microbiota in-
teractions by binding commensals inhabiting the small intestine
and, to a lesser extent, the large intestine (Bunker et al., 2015;
Kawamoto et al., 2014).
SIgA responses to commensals mostly initiate at gut follicular
sites of antigen entry, including Peyer’s patches. At these sites,
sampling of commensals by microfold cells, macrophages, and
dendritic cells promotes a sustained germinal center (GC) reac-
tion involving cognate interaction of B cells with T cells, followed
by B cell induction of IgM-to-IgA class switching and affinity
maturation through class switch recombination (CSR) and
somatic hypermutation (SHM), respectively (Kawamoto et al.,
2014). High-affinity and IgA-expressing B cells emerging from
GCs upregulate gut-homing receptors and progressively differ-
entiate into IgA-secreting plasma cells (PC-As), which home to
the gut lamina propria (LP) (Macpherson et al., 2008). These
PC-As release polymeric IgA, which translocates across epi-
thelial cells to generate intraluminal SIgA that coats mucus-
embedded commensals (Kubinak and Round, 2016).
The T cell-dependent (TD) pathway is complemented by a
T cell-independent (TI) pathway entailing activation of follicular
and possibly extrafollicular B cells by various cells of the innate
immune system (Tsuji et al., 2008). Complementary TD and TI
responses generate circulating IgA class-switched memory
(ME-A) B cells and cooperatively shape the architecture of the
microbiota during the development of an individual (Planer
et al., 2016). However, the TD pathway may become predomi-
nant over time due to continuous accumulation of ME-A B cells
(Lindner et al., 2012, 2015).
ME-AB cells emerge from gut inductive sites alongwith PC-As
and continuously diversify their B cell receptor repertoire via a
microbiota-stimulated adaptation process involving inductionhed by Elsevier Inc.
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Human PC-Ms Accumulate in the Gut together with ME-M B Cells and Include a Circulating Counterpart Expressing Gut-Homing
Receptors
(A) Flow cytometry (FCM) of IgM and IgA on CD19+CD38hiCD10 PCs from human ileum and colon.
(B) Frequency of PC-Ms among total PCs, assessed by FCM.
(legend continued on next page)
Immunity 47, 118–134, July 18, 2017 119
of SHM and PC-A differentiation in pre-existing GCs (Lindner
et al., 2012).
In addition to PC-As, the gut mucosa contains IgM-secreting
PCs (PC-Ms) that release SIgM into the lumen through the poly-
meric Ig receptor (pIgR) (Macpherson et al., 2008). In mice, SIgM
production increases upon induction of colonic damage to pre-
vent lethal dissemination of commensals (Kirkland et al., 2012).
However, little else is known about the ontogeny, regulation,
and function of SIgM, particularly in humans. A better under-
standing of this mucosal antibody may further elucidate host-
microbiota interactions in health and disease states. Indeed,
primary antibody deficiency patients selectively lacking SIgA
rarely develop inflammatory bowel disease, which is instead
more common and very severe in patients lacking both SIgM
and SIgA (Agarwal and Mayer, 2009).
We found that human PC-Ms coexisted with a large but previ-
ously unrecognized repertoire of gut-specific memory IgM+
(ME-M) B cells that were clonally related to PC-Ms as well as
some ME-A B cells and PC-As. In addition to inducing IgM-to-
IgA CSR, ME-M cells exposed to TD or TI signals secreted
copious IgM that targeted mucus-embedded commensals,
similar to SIgM from PC-Ms. Unlike its murine counterpart,
human SIgM recognized bacteria dually coated by SIgA that
were characterized by increased diversity compared to SIgA-
only-coated or uncoated bacteria. Thus, SIgM may emerge
from pre-existing ME-MB cells rather than newly activated naive
B cells and could help SIgA to anchor highly diverse microbial
communities to gut mucus.
RESULTS
Gut PC-Ms Are More Abundant in Humans than Mice
Gut PC-As have been extensively studied, but little is known
about gut PC-Ms, which account for about 10%–20% of all gut
PCs in humans (Macpherson et al., 2008). Flow cytometry
identified PC-Ms in addition to PC-As in histologically normal
resected tissues from terminal ileum and proximal colon sam-
ples of individuals undergoing right hemicolectomy due tomalig-
nancy, polyps, or angiodysplasia (Figures 1A and S1A). PC-Ms
were consistently more abundant in the ileum compared to the
colon and expressed a phenotype similar to that of class-
switched PCs, which comprised mostly PC-As (Figures 1A–1C
and S1B).
Compared to human gut naive B cells, PC-Ms showed
increased expression of CD138, CCR10, and/or CCR9. Upregu-
lation of these PC-associated molecules was coupled with(C) FCM of selected surface molecules on naive (N) B cells, PC-Ms, and switche
tensity (MFI).
(D) Immunofluorescence analysis (IFA) of IgM (green), IgA (red), and DNA (blue
magnification, 203. Scale bars, 50 mm.
(E) Number of PC-Ms (top), PC-As (center) per mm2 of LP, and PC-M/PC-A ratio (b
six different tissue samples where at least four high-power microscopic fields we
(F and G) Representative FCM (F) and frequency (G) of b7+CCR9+ cells in human
(H) Representative FCM showing IgM versus IgD staining on CD19+CD38CD10
(I) Frequency of ME-M B cells from tissues shown in (H).
(J) FCM of IgD, CD24, CD27, and CD148 on naive, ME-M, and ME-SW B cells fr
Data show one representative result (A, F, H) of 12 (B), 8 (G), or 52 (I) experiments
presented asmean ± SEM; two-tailed unpaired Student’s t test (B and E) and one-w
also Figure S1.
120 Immunity 47, 118–134, July 18, 2017downregulation of HLA-DR, CD20, and the follicle-associated
chemokine receptors CCR7 and CXCR4. Notwithstanding their
resemblance to PC-Ms, class-switched PCs expressed more
CD138, which could reflect a more advanced maturation stage
(Figure 1C and S1B; Nutt et al., 2015).
Quantitative real-time PCRs (qRT-PCRs) further determined
that, compared to human intestinal naive B cells, PC-Ms con-
tained more transcripts for BLIMP-1 and IRF4 (Figure S1C),
two transcription factors required for PC differentiation (Nutt
et al., 2015). In addition, PC-Ms contained more transcripts for
BCL-2 (Figure S1C), an anti-apoptotic protein that may sustain
human PC survival in the intestine (Nair et al., 2016). Of note,
immunofluorescence analysis followed by tissue-based cell
counting demonstrated that, compared to the human ileum LP,
the small intestinal LP from wild-type C57BL/6 mice featured
fewer PC-Ms accumulating intracellular IgM and a lower PC-
M/PC-A ratio (Figures 1D and 1E). Flow cytometry confirmed
that the frequency of PC-Ms was negligible compared to that
of PC-As in the mouse small and large intestines (Figures S1D
and S1E).
Given that PC-As colonize the small intestinal LP from the
circulation through a mechanism involving a4b7 and CCR9
gut-homing receptors (Macpherson et al., 2008), we further veri-
fied whether circulating PC-Ms expressed gut-homing proper-
ties. Compared to PC-As, a larger fraction of circulating PC-Ms
co-expressed b7 and CCR9, whereas PC-G/Es showed little or
no b7 and CCR9 (Figures 1F and 1G). Thus, PC-Ms are relatively
abundant in the human but not mouse small intestine, resemble
gut PC-As, and include a circulating fraction expressing gut-
homing receptors.
Gut PC-Ms Coexist with a Large Repertoire of ME-M
B Cells
Considering that gut PC-As emerge from ME-A B cells diversi-
fying at gut inductive sites (Lindner et al., 2015), we hypothesized
that PC-Ms coexisted with ME-M B cells in the human gut and
followed published gating strategies and comparable isolation
procedures to segregate IgM+IgDCD27+CD38 ME-M B cells
from IgM+IgDhiCD27CD38 naive, IgM+IgDloCD27+CD38
marginal zone (MZ), and IgMIgDCD27+CD38 class-switched
memory (ME-SW) B cells (Berkowska et al., 2011; Descatoire
et al., 2014). Of note, MZ B cells are heterogeneous due to pro-
gressive recruitment into GC responses that induce classical
memory traits over time, including antigen-driven selection
(Aranburu et al., 2017; Descatoire et al., 2014; Klein et al.,
1998; Seifert et al., 2015). Nonetheless, MZ B cells exhibitd PCs (PC-SW) from human ileum. Numbers indicate mean fluorescence in-
) in human ileum and mouse small intestine (SI) lamina propria (LP). Original
ottom) from human ormouse SI assessed following tissue IFA. Data summarize
re analyzed.
circulating PC-Ms, PC-As, and PC-G/Es.
 B cells from different human tissues.
om ileum.
or are from one experiment of at least 3 with similar results (C, D, J). Results are
ay ANOVAwith Tukey’s post hoc test (I). *p < 0.05, **p < 0.01, ***p < 0.001. See
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some properties that make them different from ME-M B cells,
including NOTCH-dependent but GC-independent ontogeny in
addition to IgDlo phenotype (Aranburu et al., 2017; Berkowska
et al., 2011; Descatoire et al., 2014). ME-M B cells were abun-
dant in ileum and colon but rare in blood, spleen, and tonsil
(Figures 1H and 1I). Consistent with the prevailing localization
of PC-Ms in the ileum, ME-M B cells were enriched in the ileum
compared to the colon and showed a phenotype similar to that
of ileal ME-SW B cells and splenic MZ B cells, including
increased expression of the co-stimulatory molecules CD24,
CD27, and CD148 compared to naive B cells (Figures 1H–1J
and S1F).
Next, we dissected the intestinal geography of ME-M B cells
by tissue immunofluorescence. Tissue-based cell counting re-
vealed that ME-M B cells expressing surface IgM but not IgD
were rare in the gut LP and comparably abundant in ILFs with
or without GCs (Figures 2A and 2B). Consistently, gut ME-M B
cells expressed follicle-retaining CCR7 and CXCR4 receptors
as much as gut naive and ME-SW B cells (Figure 2C). However,
kappa-deleting recombination excision circle assays detected
molecular fingerprints of GC proliferation (van Zelm et al.,
2007) in gut ME-M and ME-SW but not naive B cells (Figure 2D).
Given that ME-A B cells upregulate a4b7 and CCR9 gut-hom-
ing receptors as they recirculate from gut follicular inductive sites
to the gut LP (Macpherson et al., 2008; Nair et al., 2016), we
further determined b7 and CCR9 expression by circulating
ME-M B cells. Compared to circulating ME-A B cells and MZ B
cells, a larger fraction of circulating ME-M B cells co-expressed
b7 and CCR9, whereas naive B cells andME-G/E B cells showed
little or no b7 and CCR9 co-expression (Figures 2E and 2F).
We then ascertained whether the gut mucosa generated
ME-M B cells at an early age. Tissue immunofluorescence
analysis identified human intestinal ME-M B cells together with
PC-Ms and PC-As as early as 1.5 months of age (Figure 2G).
Tissue-based cell counting and flow cytometry indicated that
ME-M B cells remained stable over time, whereas PC-Ms
increased through the first ten years of life (Figures S1G and
S1H). Thus, human gut PC-Ms co-exist with a large and stable
repertoire of ME-M B cells that emerge early in life, predomi-
nantly inhabit gut follicles, and include a circulating fraction ex-
pressing gut-homing receptors.
Gut ME-M B Cells Express a Gene Signature Reflecting
Antigen Experience
Human intestinal ME-M B cells were further characterized
through transcriptomics. These studies were preceded by aFigure 2. Human Gut ME-M B Cells Inhabit Mucosal Follicles, Show
Homing Receptors, and Emerge Early in Life
(A) IFA of IgM (green), IgD (red), and DNA (blue) in human ileum tissue sections. B
603 (right). Scale bars, 50 mm.
(B) Number of IgM+IgD ME-M B cells from human intestine calculated by coun
tissue samples where at least four microscopic fields were analyzed.
(C) FCM of CCR7 and CXCR4 on naive, ME-M, and ME-SW B cells from human
(D) Replication history analyzed by KREC assay. Dashed line corresponds to pas
(E and F) Representative FCM (E) and frequency (F) of human circulating b7+CCR
(G) IFA of IgM (green), IgD (red), IgA (magenta), and DNA (blue) in intestinal tissu
fication, 103 (top left), 203 (top right), 43 (mid left), 403 (mid right), 103 (bottom
Data are from 1 of at least 3 experiments with similar results (A, C, G), summariz
Results are presented as mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001 (two-ta
122 Immunity 47, 118–134, July 18, 2017morphological analysis that confirmed the specificity of our
sorting procedures (Figure 3A).
The global gene expression profile of ME-M B cells was eluci-
dated through cross-comparative strategies involving memory B
cell subsets from gut or spleen, including splenic MZ B cells. In
this approach, eachsubsetwascompared to tissue-specificnaive
B cells. Supervised hierarchical clustering and robust multi-array
average expression analysis indicated that ME-M B cells ex-
pressed a transcriptome distinct from that of naive B cells, but
similar to that of ME-SWB cells, irrespective of the tissue of origin
(Figures 3B and S2A). Venn diagrams further determined that gut
ME-M B cells expressed a common memory B cell signature en-
tailing 215 transcripts, which were also differentially expressed
by gut ME-SW B cells as well as splenic ME-SW and MZ B cells
(FigureS2B). ThiscommonmemoryBcell genesignature included
increased expression of TACI (TNFRSF13B) alongwith decreased
expression of IgD (IGHD), CD72, and the transcriptional suppres-
sors of PCdifferentiation FOXO1, BTLA, andBACH2 (Figures S2C
and S2D; Kurosaki et al., 2015; Nutt et al., 2015). Thus, human gut
ME-MBcellsexpressacommonmemoryBcell genesignature re-
flecting increased propensity to undergo activation, proliferation,
and PC differentiation.
Gut ME-M B Cells Express a Tissue-Specific Gene
Signature
As shown by unsupervised hierarchical gene clustering and prin-
cipal component analysis, gutME-M andME-SWB cells also ex-
pressed a tissue-specific signature. Indeed, these B cells clus-
tered together but away from splenic ME-SW and MZ B cells,
whereas naive B cells grouped together independently of their
tissue of origin (Figures 3B, S2E, and S2F). Pairwise correlations
confirmed that gut ME-M B cells were more robustly affiliated to
gut ME-SW B cells than to splenic MZ B cells (Figure 3C).
Accordingly, volcano plot, Venn diagram, and heatmap dia-
grams coupled with qRT-PCR showed 305 transcripts differen-
tially expressed by gut ME-M and ME-SW B cells but not
splenic ME-SW and MZ B cells compared to naive B cells
(Figures 3D–3F and S3A).
This tissue-specific memory signature included increased
expression of transcripts for (1) activation-induced receptors
such as FcRL4, CD11c (ITGAX), and Siglec-6; (2) IgA
response-related transcription factors such as RUNX2 and
RORA; (3) PC-inducing molecules such as IL-10, IL10RA,
CD70, and the transcription factor ZBTB32; and (4) epithelium-
targeting chemokine receptors such as CCR1, CCR2, and
CCR9 (Figures 3D–3F and S3A; Ehrhardt et al., 2005; JashPost-GC Traits, Include a Circulating Counterpart Expressing Gut-
oxes correspond to enlarged right images. Original magnification, 203 (left) or
ting cells/mm2 following tissue IFA. Data summarize results from five different
ileum and colon.
t cell divisions in control GC B cells from human tonsils.
9+ B cells.
es from children. Boxes correspond to enlarged right images. Original magni-
left), and 403 (bottom right). Scale bars, 50 mm.
e 3 experiments (D), or show 1 representative result (E) of 24 experiments (F).
iled unpaired Student’s t test). See also Figure S1.
(legend on next page)
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et al., 2016; Nair et al., 2016; Rubtsov et al., 2015; Wang et al.,
2012; Watanabe et al., 2010). Finally, Ingenuity’s upstream regu-
lator analysis indicated that, compared to splenic ME-SW and
MZ B cells, gut ME-M and ME-SW B cells expressed functional
gene sets predicting enhanced signaling from IL-2, IL-5, IL-6, IL-
10, IL-15, andGM-CSF pathways (Figure 3G), which are linked to
B cell activation and PC differentiation (Nutt et al., 2015).
Consistent with these data, gut ME-M and ME-SW B cells ex-
pressed activation traits encompassing upregulation of FcRL4,
CD43, and CD11c combined with downregulation of CD62
ligand expression (Figure 3H). However, compared to gut
ME-SW B cells, gut ME-M B cells also showed enhanced MZ-
like traits (Figure 3I), including increased expression of CD21,
CD35, CD1c, and the adhesion molecule CD66a (Descatoire
et al., 2014; Seifert et al., 2015). Notwithstanding these similar-
ities, supervised gene expression analysis, flow cytometry, and
gene set enrichment analysis (GSEA) indicated that gut ME-M
B cells were distinct from splenic MZ B cells (Figures S3B–
S3E). Indeed, gut ME-M B cells expressed less CD84 (Fig-
ure S3B), a member of the SLAM family highly expressed by
innate-like lymphocytes (Sintes et al., 2010). Furthermore, gut
ME-M B cells expressed more gene products implicated in
IL-2 and IL-6 receptor signaling via STAT proteins, but fewer
gene products implicated in NOTCH signaling (Figures S3C–
S3E). Thus, human gut ME-M B cells express a tissue-specific
memory gene signature reflecting increased immune activation
and PC but not MZ differentiation.
Gut ME-M B Cells Are Clonally Related to PC-Ms
and Some PC-As
We next characterized the Ig heavy chain variable (IGHV) and
joining (IGHJ) gene repertoires of gut ME-M B cells from paired
ileum and colon samples to broadly determine their degree of
similarity and diversity with naive B cells and PC-Ms as well as
class-switched ME-A B cells and PC-As. Pearson’s correlation
coefficient analysis of IGHV gene usage indicated that gut ME
B cell and PC subsets differed from gut naive B cells but hierar-
chically clustered with each other based on the expressed iso-
type, tissue of origin, and cell type (Figures 4A and S4A). The
antigen-driven IGHV gene reconfiguration of gut ME B cell and
PC subsets was further inferred from their negative selection of
IGHV1-18, IGHV1-69, IGHV4-34, and IGHJ6 genes (Figures 4B
and S4A) and positive selection of IGHV3-7, IGHV3-23, and
IGHJ4 genes (Figures S4A and S4B).Figure 3. Human Gut ME-M B Cells Are Transcriptionally Distinct from
That Includes Multiple Activation Traits
(A) May-Gr€unwald-Giemsa staining of sorted human intestinal cells. Original mag
(B) Dendrogram of unsupervised agglomerative hierarchical cluster analysis and g
naive, ME-M, and ME-SW B cells sorted from human ileum or naive, MZ, and M
(C) Scatterplot depicting robust multi-array average normalized expression.
(D) Venn diagram showing transcripts exclusively differentially expressed by ME
(E) Volcano plot representation of genes differentially expressed by ME-M B cell
(F) qRT-PCR of mRNAs encoding selected genes in B cell population as in (B).
(G) Ingenuity’s upstream regulator comparison analysis showing selected upst
(p value > jlog105j).
(H and I) FCM of selected surface molecules on naive, ME-M, and ME-SW B cel
Data are from one of three experiments with similar results (A, H, I), summarize re
experiments from at least three different donors (F). Mean ± SEM; *p < 0.05; **p
and S3.
124 Immunity 47, 118–134, July 18, 2017Compared to gut naive B cells, gut ME B cell and PC subsets
expressed mutated IGHV genes encoding antigen-binding vari-
able regions with shorter H-CDR3 average length (Figures 4C,
S4C, and S4D), two additional hallmarks of antigen-driven selec-
tion (Lindner et al., 2012, 2015; Tipton et al., 2015). In addition to
these commonalities, gut ME B cell and PC subsets showed sig-
nificant differences. In particular, ME-M B cells and PC-Ms
featured fewer IGHV gene mutations and shorter H-CDR3
compared to ME-A B cells and PC-As from ileum but not colon
(Figures 4C, S4C, and S4D). Moreover, ME-M B cells expressed
more Ig light chain l (Igl) compared to ME-A B cells from ileum
but not colon (Figure 4D). These differences could reflect the
involvement of ME-M B cells in antigen-driven selection and
differentiation programs distinct from those regulating ME-A
B cells.
We then investigated the dynamics of the inferred gut antibody
repertoire from each donor by collapsing all clones into clonal
families and comparing the resulting ‘‘core repertoire’’ to the
original ‘‘expanded repertoire.’’ Clonal families expressing both
IgM and IgA or inhabiting both ileum and colon were expanded
compared to the core repertoire, whereas clonal families ex-
pressing only IgM or IgA or inhabiting either ileum or colon
were not (Figure S4E). These observations indicate that clonal
expansion is coupled with increased IgM-to-IgA class switching
and intestinal dissemination. We next visualized the ontogenetic
affiliations of gut ME-M B cells with other ME B cell and PC sub-
sets through circos plots. While most of these clonally related
ME-M B cells were linked to PC-Ms inhabiting identical or
distinct gut segments, fewer but large ME-M clonotypes
harboring an increased number of IGHV gene mutations were
linked to ME-A B cells and/or PC-As (Figures 4E, 4F, S5A,
and S5B).
Clonotypic affiliations were further corroborated through
the calculation of theMorisita-Horn overlap index, which ascribes
0 and 1 values to unrelated and identical sequences, respectively
(Lindner et al., 2015). Ileal ME-M clonotypes showed very robust
relatedness with ileal PC-M clonotypes and less robust related-
ness with all other subsets clonotypes (Figures 4G and S5C).
Further dissection of clonal families through lineage tree recon-
struction analysis suggested that some ileal ME-M B cells
generate colonic PC-Ms or ileal ME-A B cells upon re-entering
GC pathways that induced SHM with or without CSR (Figures
4H and 4I). Additional ileal ME-M B cells from ileummay generate
colonic PC-As by entering extra-GC pathways inducing CSR butNaive B Cells and Express a Tissue-Specific Memory Gene Signature
nifications 1003.
ene expression heatmap diagram displaying genes differentially expressed by
E-SW B cells from human spleen.
-M and ME-SW B cells versus naive B cells from human ileum.
s versus naive B cells from human ileum. Selected genes are highlighted.
ream regulators among cytokine and growth factors differentially expressed
ls from human ileum.
sults from four biological replicates (B–E, G), or summarize three independent
< 0.01; ***p < 0.001 (two-tailed unpaired Student’s t test). See also Figures S2
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not SHM (Figure 4J). Accordingly, tissue immunofluorescence
analysis detected B cells expressing the CSR/SHM-inducing
enzyme AID and the proliferation molecule Ki-67 in both GC
and extra-GC areas from ileum, including ILFs (Figure 4K).
The presence of IgM-to-IgA CSR in some gut ME-M B cells
was confirmed by detecting germline Ia1-Ca1 and Ia2-Ca2 as
well as switch circle Ia1/2-Cm transcripts inME-M but not control
naive B cells from human ileum (Figures 4L and S5D). Ileal IgM+
GC B cells predictably contained Ia1-Ca1 and Ia1/2-Cm,
whereas PC-Ms unexpectedly contained Ia1/2-Cm and Ia2-
Ca2 but lacked Ia1-Ca1 (Figure 4L). These PC-Ms may emerge
from recently activated ME-M clones concomitantly receiving
IgM-to-IgA CSR-inducing signals. Thus, human ME-M B cells
disseminate to both ileum and colon and may differentiate to
PC-Ms and class-switched PC-As by re-entering GCs or pro-
gressing through extra-GC pathways.
GutME-MBCells Secrete IgMandSwitch to IgA uponTD
or TI Stimulation
The differentiation potential of human gut ME-M B cells was
further explored by evaluating their proliferation, CSR and PC
differentiation upon exposure to TD (CD40L and IL-21) or TI
(CpG DNA combined or not with BAFF and APRIL) signals. IL-
10 was supplemented to maximize CSR and PC differentiation
(Macpherson et al., 2008).
As shown by CFSE dilution assays, TD signals induced com-
parable proliferation of gut ME-M and naive B cells, whereas TI
signals induced proliferation of gut ME-M but not naive B cells,
particularly in the presence of BAFF and APRIL (Figures 5A
and 5B). Moreover, ME-M B cells differentiated into proliferating
CD38hiCFSElo plasmablasts in response to either TD or TI sig-
nals, whereas naive B cells did so only in response to TD signals
(Figure 5C). Of note, a sizable fraction of plasmablasts emerging
from activated ME-M but not naive B cells expressed IgA but
lacked IgM (Figure 5D).
Consistent with these data, ME-M B cells secreted copious
IgM and less abundant IgA in response to TD or TI signals,
whereas naive B cells showed weaker IgM and IgA responses
to TD but not TI signals (Figure 5E). We then wondered whether
CSR targeted gut ME-M B cells expressing FcRL4, which de-
fines activated tissue-based memory B cells (Ehrhardt et al.,
2005). Indeed, TD signals generated plasmablasts from both
FcRL4 and FcRL4+ ME-M B cells, but induced IgM-to-IgA
CSR only in FcRL4+ ME-M B cells (Figure 5F). Accordingly, gutFigure 4. Human Gut ME-M B Cells Express a Post-GC Mutational Pro
(A) Pearson’s correlation coefficient matrix of IGHV gene usage by naive B cells an
colon grouped by hierarchical clustering algorithm according to common gene s
(B and C) Relative mean frequency of IGHJ6 gene usage and mean number of IG
(D) Frequency of Igl-expressing cells calculated by FCM.
(E and F) Circos plots depicting clonal relationships and IGHV gene mutations.
(G) Morisita-Horn index showing clonal repertoire overlap between ME-M B cells
(H–J) Lineage tree reconstruction of inferred clonal families (colored circles) and th
numbers indicate mutations accumulated along the lineage tree.
(K) IFA of ILFs from human ileum stained for AID (green), Ki-67 (red), and DNA (blue
(top) or 403 (bottom). Scale bars, 50 mm.
(L) PCR of switch circle Ia-Cm transcripts (SCTs) as well as germline Im-Cm, Ia-Ca
from human ileum.
Data are from 1 representative donor (E, F, H–L) or summarize results from 4 differ
test and one-way ANOVA with Tukey’s post hoc test). See also Figures S4 and S
126 Immunity 47, 118–134, July 18, 2017FcRL4+ but not FcRL4 ME-M B cells contained transcripts for
the CSR (and SHM)-inducing enzyme AID (Figure 5G). Thus,
human gut ME-M B cells proliferate and generate PC-Ms in
response to TD or TI signals, which further induce IgM-to-IgA
CSR in the FcRL4+ fraction of ME-M B cells.
Gut ME-M B Cells and PC-Ms Release IgM
to Mucus-Embedded Commensals
We next developed an EBV-based protocol to determine
whether human gut ME-M B cells produced IgM to autologous
mucus-embedded bacteria (Figure 6A). Initial ELISAs showed
that IgM from ileal ME-MBcells recognized commensal antigens
such as phosphorylcholine, b-glucan, laminarin, galactose-
a-1,3-galactose, and capsular polysaccharides, whereas IgM
from ileal naive B cells did not (Figures 6B and S6A). Further
flow cytometry assays showed that IgM from ileal ME-M B cells
recognized mucus-embedded commensals more efficiently
than IgM from ileal naive B cells did (Figure 6C).
We then quantified binding of PC-derived SIgM to mucus-
embedded microbiota from paired human ileum and colon sam-
ples (Figures 6D, S6B, and S6C). Initial ELISAs detected free
SIgM in mucus, though in lesser amounts than free SIgA (Fig-
ure 6E). Most mucus samples included significant SIgA+SIgM+,
SIgA+SIgM, and SIgASIgM but negligible SIgASIgM+
microbiota fractions (Figure 6F). The frequency of these fractions
was variable among individuals and between ileum and colon
from the same individual. Consistent with the virtual lack of
PC-Ms in the murine gut and published results (Bunker et al.,
2015), the microbiota from the small and large intestines of
wild-type mice included IgASIgM and SIgA+SIgM but not
SIgA+SIgM+ bacterial fractions (Figure 6G). Enhancing gut
microbiota complexity by housing mice outside the specific
pathogen-free (SPF) barrier increased neither SIgA+SIgM+
bacteria nor PC-Ms nor PC-As, but did increase SIgA+SIgM
bacteria (Figures S6D and S6E). Thus, human gut ME-M B cells
recognize commensals as clonally related PC-Ms do. These
latter generate homeostatic SIgM responses that target SIgA-
coated bacteria in humans but not wild-type mice.
SIgM fromGut PC-MsBindsHighly DiverseCommensals
Dually Coated by SIgA
We next devised a strategy to profile mucus-embedded
bacteria from human ileum or colon by 16S ribosomal RNA
(rRNA) gene sequencing and found inter-individual variabilityfile and Clonally Relate to Gut PC-Ms and Some PC-As
d paired ME-M B cells, ME-A B cells, PC-Ms, and PC-As from human ileum or
et usage. Circle size and color saturation indicate correlation strength.
HV gene mutations per 100 bp in gut B cell and PC subsets as in (A).
from human ileum and all other B cell subsets as in (A).
eir inferred germline (GL) and intermediate precursors (gray circles). Edges and
). Insets correspond to boxed areas inmain images. Original magnification, 203
1, and Ia-Ca2 transcripts (GTs) in naive, ME-M, and IgM+ GC B cells or PC-Ms
ent donors (A–D, G). Error bars, SD; *p < 0.05, **p < 0.01, ***p < 0.001 (Welch’s t
5.
(legend on next page)
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at phylum and genus levels (Figures S7A–S7C). Differences in
bacterial composition between ileum and colon from the
same donor were less pronounced than between donors, as
shown by unsupervised hierarchical clustering (Figure S7C).
Rarefaction plots calculating Faith’s phylogenetic diversity
and Shannon index confirmed that phylogenetic richness and
species diversity varied among donors but not between tissues
(Figures S7D and S7E).
To comparatively profile SIgA+SIgM+, SIgA+SIgM, and SIgA
SIgM fractions of mucus-embedded bacteria in a com-
prehensive and unbiased manner, we combined SIgM/A-based
sorting with 16S rRNA gene sequencing (Figure 7A). The compo-
sition of each fraction varied at both phylum and genus levels,
though all fractions showed more Bacteroidetes and Firmicutes
than Proteobacteria and Actinobacteria (Figures 7B and 7C).
Also, phylogenetic richness and microbial species diversity var-
ied among fractions, with an overall decrease from SIgA+SIgM+
to SIgA+SIgM and SIgASIgM fractions (Figure 7D). This
finding correlated with differences in phylum composition,
including proportionally fewer Bacteroidetes but more Firmi-
cutes in SIgA+SIgM+ compared to SIgA+SIgM and SIgASIgM
fractions (Figure 7E).
To identify microbial species accounting for the above
phylum differences at the operational taxonomic unit (OTU)
level, we used a log-based enrichment index (Figure 7F). A
hierarchical clustering algorithm applied to a conservative
selection of OTU-based enrichment indexes showed that
SIgA+SIgM+ and SIgA+SIgM fractions grouped together,
separately from the SIgASIgM fraction (Figure 7F). Of twelve
OTUs showing a significantly different enrichment index, seven
Lachnospiraceae and Ruminococcaceae were enriched in
SIgA+SIgM+ compared to SIgASIgM bacteria (Figures 7F
and S7F).
Accordingly, flow cytometry-based coating assays deter-
mined that IgM from EBV-transformed gut ME-M B cell lines
strongly bound Firmicutes such as Bacillus cereus, Rosebu-
ria intestinalis (belonging to Lachnospiraceae), and Rutheni-
bacterium lactatiformans (belonging to Ruminococcaceae).
In addition, IgM showed elevated binding to Bacteroidetes
such as Bacteroides vulgatus, but little or no binding to
other Bacteroidetes or Proteobacteria such as Bacteroides
fragilis, Bacteroides thetaiotamicron, and Escherichia coli
(Figure S7G). Thus, human SIgM may cooperate with
SIgA to implement mucus retention of diverse microbial
communities, including Firmicutes with putative beneficial
functions.Figure 5. HumanGutME-MBCells Undergo Proliferation, PCDifferenti
Signals
(A and B) FCM of CFSE dilution profiles (A) and GeoMean (% of max) of CFSE sta
indicated. Ctrl, medium alone.
(C) FCM of CFSE and CD38 on naive (top) and ME-M (bottom) B cells from hum
CD38hiCFSElo PCs.
(D) FCM of IgM and IgA on CD38hiCFSElo plasmablasts emerging upon stimulati
(E) ELISA of IgM and IgA secreted by naive (N) and ME-M B cells from human ile
(F) FCM of CD38, CD27, IgM, and IgA on sorted FcRL4 (left) or FcRL4+ (right) M
CD40L, IL-21, and IL-10.
(G) qRT-PCR analysis of mRNA encoding AID (AICDA) in naive, FcRL4 ME-M, a
Data represent one representative experiment of twowith similar results (A–D, F) o
mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001 (two-tailed unpaired Student’s t
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We have shown that human gut PC-Ms were clonally related to a
large and previously unrecognized repertoire of ME-M B cells
that predominantly inhabited gut-associated follicles. Besides
undergoing IgM-to-IgA CSR in response to TD or TI signals,
gut ME-M B cells secreted abundant IgM, which, along with
SIgM, recognized mucus-embedded commensals. Of note,
SIgM-coated bacteria were dually targeted by SIgA and showed
increased diversity and distinct composition compared to un-
coated or SIgA-only-coated bacteria. Thus, SIgM may help
SIgA to anchor non-redundant microbial communities to mucus.
The key role of SIgA in gut homeostasis can be inferred from
the emergence of dysbiosis in mice lacking B cells, IgA, AID, or
pIgR (Kubinak and Round, 2016). In addition to dysbiosis, pa-
tients with antibody deficiency can develop gut inflammation,
including inflammatory bowel disease (Agarwal and Mayer,
2009). This complication is more frequent in common variable
immunodeficiency cases with combined SIgM and SIgA deple-
tion (Agarwal and Mayer, 2009), suggesting that human gut
homeostasis requires microbiota targeting by both SIgM and
SIgA. Accordingly, we found that PC-Ms accumulated in the
human but not mouse gut mucosa and further demonstrated
that SIgM coated human but not mouse gut bacteria in combina-
tion with SIgA.
Remarkably, human gut PC-Ms established extensive clonal
relationships with a large repertoire of gut ME-M B cells that
were rare in systemic or mucosal extra-intestinal lymphoid or-
gans, including spleen and tonsils. The prominent gut tropism
of ME-M B cells was further indicated by studies showing robust
a4b7 and CCR9 co-expression on a large fraction of circulating
ME-M B cells and PC-Ms. Of note, a4b7 and CCR9 induction
mostly occurs in lymphoid structures from the small intestine
and promotes migration of gut ME-A B cells and immature
PC-As to the small intestinal LP (Macpherson et al., 2008).
Accordingly, gut ME-M B cells predominantly inhabited Peyer’s
patches and ILFs from the small intestinal mucosa, whereas
PC-Ms mostly accumulated in the small intestinal LP. Similar
to PC-As, gut ME-M B cells and PC-Ms became detectable as
early as 1.5months after birth. While PC-Ms further accumulated
over the first 10 years of life, ME-M B cells remained numerically
stable over time. These results suggest that SIgMmay shape the
microbiota of a developing individual in cooperation with SIgA
(Planer et al., 2016).
Our identification of clonally related ME-M B cells and PC-Ms
in the human gut extends evidence from mouse systemication, IgMSecretion, and IgAClass Switching in Response to TD or TI
ining (B) in naive (N) and ME-M B cells from human ileum cultured for 5 days as
an ileum cultured as in (A) and (B). Numbers indicate percent of newly formed
on as in (A) and (B).
um cultured for 5–7 days as in (A) and (B).
E-M B cells from human ileum cultured for 5 days with medium alone (ctrl) or
nd FcRL4+ ME-M B cells from human ileum.
r summarize at least three different experiments (E, G). Results are presented as
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immunization models indicating that humoral memory is not
merely comprised ofME-G andME-A B cells, but further extends
to ME-M B cells (Dogan et al., 2009; Kurosaki et al., 2015; Pape
et al., 2011). Besides expressing canonical memory molecules
such as CD24, CD27, and CD148, human gut ME-M B cells
featured post-GC expression of mutated IGHV genes and nega-
tive selection of IGHV1-69, IGHV4-34, and IGHJ6 genes, which
encode antibodies enriched in self-reactivity (Tipton et al.,
2015). Furthermore, some ME-M B cells showed clonal proper-
ties consistent with re-entry into GC pathways promoting SHM
in addition to PC-M differentiation.
Diversification of human gut PC-Ms from pre-existing memory
specificities echoes works showing homeostatic or immuniza-
tion-induced diversification of gut ME-A B cells in GCs from
Peyer’s patches (Bemark et al., 2016; Lindner et al., 2012,
2015). In addition to PC-Ms, human gut ME-M B cells generated
some ME-A B cells and PC-As by entering either GC pathways
coupled with SHM and CSR or GC-independent pathways pro-
moting CSR but not SHM. This conclusion was supported by
lineage tree reconstruction analysis of high-throughput IGHV
gene sequencing data, detection of AID in activated FcRL4+
gut ME-M B cells responsive to IgM-to-IgA CSR-inducing sig-
nals, identification of IgM-to-IgA CSR in unfractioned ME-M B
cells, and detection of AID in B cells from both GC and extra-
GC areas.
In mice, systemic ME-G and ME-M B cells were thought to
rapidly induce PC-Gs or a secondary GC reaction upon re-expo-
sure to antigen, respectively (Dogan et al., 2009; Pape et al.,
2011). This view has been modified by mouse studies indicating
that systemic ME-M B cells can rapidly differentiate into IgG
class-switched plasmablasts in response to TI or TD signals
(Krishnamurty et al., 2016; Zuccarino-Catania et al., 2014).
Accordingly, human intestinal ME-MB cells progressed along in-
tertwined GC-dependent and GC-independent pathways that
promoted IgM-to-IgA CSR in addition to PC differentiation.
Compared to gut naive B cells, which showed weaker and TD-
biased antibody responses, gut ME-M B cells comparably
induced plasmablasts secreting IgM or IgA in response to either
TD or TI signals. Of note, similar signals activate rotavirus-spe-
cific gut ME-M B cells (Narva´ez et al., 2012). Local TD and TI
cues could further imprint ME-M B cells with a tissue-specific
memory signature similar to that described in tonsillar ME-G/A
B cells (Ehrhardt et al., 2005). This signature included CD11c,
Siglec-6, CCR9, IL-10, IL-10Ra, and RORa upregulation, which
reflects non-inflammatory activation and mucosal homing.
Gut ME-M B cells also expressed a common memory signa-
ture shared with gut and splenic ME-SW B cells. This signatureFigure 6. Human IgM from Gut ME-M B Cells and SIgM from Gut PC-M
Coated by SIgA
(A) Strategy used to test reactivity of IgM secreted by human ME-M B cells and
(B) ELISA measuring reactivity for phosphorylcholine (PCh) and b-glucan of IgM
(C) Reactivity of IgM from naive (N) or ME-M B cells to SYTO BC+ mucus-embed
(D) Experimental strategy used to measure free and microbiota-bound SIgM and
(E) ELISA of free SIgM (blue) and SIgA (red) in mucus samples.
(F and G) FCM of SIgA and SIgM bound to viable SYTO BC+ microbiota from hum
lumen of wild-type C57BL/6 mice housed under SPF conditions (G).
Data summarize at least 3 (B, C, bottom graph), 12 (E), or 20 (F, G, right graphs) exp
cytogram and profiles; F, G left cytograms). Two-tailed paired Student’s t test (C, E
as mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S6.
130 Immunity 47, 118–134, July 18, 2017included FcRL4 and TACI upregulation, which suggests in-
creased activation by TI signals from TLR ligands and BAFF or
APRIL (He et al., 2010; Sohn et al., 2011), as well as CD72,
FOXO1, BACH2, and BTLA4 downregulation, which reflects
increased propensity to undergo proliferation and PC differenti-
ation (Kurosaki et al., 2015). Similar to splenic MZ B cells, gut
ME-M B cells expressed more CD1c, CD21, CD35, and CD66a
compared to gut ME-SW B cells, a finding reminiscent of recent
studies suggesting that splenicMZB cells originate from gut pre-
cursors (Vossenk€amper et al., 2013). However, the global tran-
scriptome of gut ME-M B cells clustered separately from that
of splenic MZ B cells. Compared to these latter, gut ME-M B
cell expressed less CD84, more gene products linked to PC-
inducing IL-2 and IL-6 signaling, and fewer gene products linked
to NOTCH signaling, which is required for MZ B cell differentia-
tion (Descatoire et al., 2014).
Besides establishing affiliations with IgM+ and IgA+ clono-
types, ME-M B cells formed a core repertoire of clonally orga-
nized families that emerged early in life and did not show age-
dependent accumulation. Thus, ME-M B cells may form a stable
but functionally plastic pool of ‘‘immune sentinels’’ within sites of
antigen entry, such as ILFs. These sites contained two parallel
repertoires of unswitched ME-M and naive B cells expressing
follicle-targeting CCR7 and CXCR4 receptors. As indicated by
their unique phenotypic, molecular, transcriptional, and func-
tional traits, these B cell subsets may offer unique solutions to
different problems. While ME-M B cells may initiate quickly
developing SIgM and SIgA responses to rapidly match transient
changes of the microbiota, naive B cells may induce de novo
SIgM and SIgA responses to counter more durable microbial
perturbations. Consistent with their involvement in the homeo-
static control of commensals, ME-M B cells produced IgM
to mucus-embedded bacteria as SIgM from clonally related
PC-Ms did.
The presence of homeostatic SIgM responses in humans but
not mice may reflect the lower complexity of the mouse gut
microbiota (Kamada et al., 2013). However, neither PC-Ms nor
SIgM-coated bacteria increased in non-SPF mice harboring a
more complex microbiota, suggesting that B cell-intrinsic differ-
ences also play a role. Accordingly, ME-M B cells from orally
immunized mice have been shown to colonize the spleen and
bone marrow but not gut follicles (Bemark et al., 2016). Remark-
ably, SIgM coated a fraction of the human microbiota that was
also targeted by SIgA. Compared to uncoated or SIgA-only-
coated bacteria, bacteria dually coated by SIgM and SIgA
showed increased diversity, a parameter linked to gut homeo-
stasis (Kamada et al., 2013). By activating complement (Kirklands Target Mucus-Embedded Commensals, Including Bacteria Dually
control naive (N) B cells from human ileum. LCL, lymphoblastoid cell line.
secreted by EBV-transformed naive or ME-M B cells from human ileum.
ded microbiota.
SIgA from human gut mucus.
an ileum or colon mucus (F) or from small intestine (SI) and large intestine (LI)
eriments in addition to showing results from one representative experiment (C,
) and one-way ANOVAwith Tukey’s post hoc test (F, G). Results are presented
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et al., 2012), SIgM may constrain the growth of common com-
mensals, thereby helping SIgA to optimize microbiota diversity
(Kubinak and Round, 2016). Accordingly, SIgA deficiency
causes dysbiosis and inflammatory bowel disease when com-
bined with SIgM deficiency, as in patients with common variable
immunodeficiency (Agarwal and Mayer, 2009).
Compared to uncoated bacteria, bacteria dually coated by
SIgM and SIgA as well as bacteria coated by SIgA alone were
enriched in Firmicutes, including Lachnospiraceae and Rumino-
coccaceae. By degrading dietary polysaccharides into short-
chain fatty acids with immunoregulatory and SIgA-inducing
functions (Arpaia et al., 2013; Kim et al., 2016), these commen-
sals may enhance protection against obesity and infection (Bid-
dle et al., 2013; Cho et al., 2012; Petrof et al., 2013). Should this
be the case, PC-Ms and clonally related PC-As may maximize
gut retention of non-redundant microbial consortia through a
mechanism involving mucus interaction with the pIgR-derived
secretory fragment of SIgM and SIgA (Macpherson et al.,
2008). This dual anchoring strategy may have evolved to pre-
serve microbiota homeostasis under common pathological con-
ditions selectively depleting SIgA. Similar to a large fraction of
gut IgA (Benckert et al., 2011), gut IgM showed evidence of poly-
reactivity, because it targeted common microbial products and
some Bacteroidetes such as Bacteroides vulgatus in addition
to Firmicutes. In summary, SIgM may emerge from pre-existing
memory rather than newly activated naive IgM+ B cells and could
help SIgA to select, control, and retain highly diverse and puta-
tively beneficial commensal communities within gut mucus.
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Bacteroides thetaiotaomicron ATCC 29148
Biological Samples
Histologically normal tissue samples from
terminal ileum and ascending colon
Patients undergoing right hemicolectomy-
Hospital del Mar
N/A
Histological normal spleens Hospital Clinic N/A
Tonsils Patients undergoing tonsillectomy-Hospital
del Mar
N/A
Blood samples BST-Barcelona N/A
Chemicals, Peptides, and Recombinant Proteins
4’,6-Diamidine-2-phenylindole
dihydrochloride (DAPI)
Sigma-Aldrich 28718-90-3
Ficoll-Paque PLUS GE Healthcare 17144003
Collagenase IV ThermoFischer 17104019
DNase New England Biolab M0303S
b-D-glucan from barley Sigma 9041-22-9
Capsular polisaccharides (serotypes 9N,
14, 19F, 23F)
ATCC N/A
Gal-a1,3-gal-HSA (3 atom spacer) Dextra Laboratories NGP2203
Laminarin from Laminaria digitata Sigma-Aldrich 9008-22-4
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REAGENT or RESOURCE SOURCE IDENTIFIER
L-a-Phosphatidylcholine Sigma-Aldrich 8002-43-5
megaCD40L Enzo Life science ALX-522-110-C010
TMB Substrate reagent set BD bioscience 555214
IL-10 Peprotech 200-10
IL-21 Peprotech 200-21
CpG ODN-2006 ThermoFischer tlrl-2006
BAFF (soluble)(human),(recombinant) Enzo ALX-522-025-C010
MEGACD40L
(soluble)(human),(recombinant)
Enzo ALX-522-110-C010
APRIL (human) (H98) (multimeric) Adipogen AG-40B-0088
FcR Blocking Reagent, human Miltenyi 130-059-901
FluorSave reagent Merck Millipore 345789
Syto BC ThermoFischer S34855
Critical Commercial Assays
Giemsa Stain Kit (Jenner-Wright) Agilent AR308
CellTrace CFSE cell proliferation Kit ThermoFisher C34554
TaqMan Reverse Transcription Reagents ThermoFisher N8080234
Nextera XT DNA Sample Preparation Kits Illumina 1502354
Pure Link Microbiome DNA Purification Kit ThermoFisher A29790
Quiamp DNA Mini Kit QIAGEN Cat# 51304
RNeasy Micro Kit QIAGEN Cat# 74004
AmpliTaq Gold PCR mastermix ThermoFisher 4398881
Power SYBR Green PCR Master Mix ThermoFisher 4367659
Deposited Data
Microarray data This Paper GEO: GSE89282
NGS data This Paper BioProject: PRJNA355402
Experimental Models: Cell Lines
EBV producing marmoset B cell line (B95-8) ECACC 85011419
EBV transformed cell lines This Paper N/A
Oligonucleotides
Primers for RT-PCR see Table S1 This paper N/A
Primers for CSR see Table S2 This paper N/A
Primers for NGS see Table S4 This paper N/A
Software and Algorithms
FlowJo v10.0.7 FlowJO https://www.flowjo.com/
Fuji (ImageJ) ImageJ https://fiji.sc/
Gene Set Enrichment Analysis (Subramanian et al., 2005) http://software.broadinstitute.org/gsea/
index.jsp
limmaGUI (Wettenhall and Smyth, 2004) https://www.bioconductor.org/packages/
release/bioc/html/limmaGUI.html
pRESTO (Vander Heiden et al., 2014) https://presto.readthedocs.io
IgBLAST (Ye et al., 2013) https://www.ncbi.nlm.nih.gov/igblast/
Change-O (Gupta et al., 2015) https://changeo.readthedocs.io
R package N/A http://www.R-project.org/
IgTree Software (Barak et al., 2008) http://immsilico2.lnx.biu.ac.il/
Software.html
QUIIME (Caporaso et al., 2010) http://qiime.org/
Prism v.6.0 GraphPad www.graphpad.com
Ingenuity Pathway Analysis QIAGEN https://www.qiagenbioinformatics.com/
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Andrea
Cerutti (acerutti@imim.es).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Tissue and Blood Specimens
Histologically normal tissue samples from terminal ileum and ascending colon were obtained from 50 patients undergoing right
hemicolectomy due to colonic tumors, unresectable polyps or angiodysplasia. The age of these patients ranged from 28 to 89 years
(mean 68.8 years) and the male/female ratio was 1:1.2. Peripheral mononuclear cells were isolated from buffy coats and splenocytes
from histologically normal spleens from deceased organ donors or individuals undergoing post-traumatic splenectomy. Tonsils were
obtained from adult patients with follicular hyperplasia. The use of blood and tissue samples was approved by the Ethical Committee
for Clinical Investigation of the Institut Hospital del Mar d’ InvestigacionsMe`diques (CEIC-IMIM 2011/4494/I). Fresh tissue andmucus
samples and formalin-fixed and paraffin-embedded tissue sections were collected from the Mar Biobanc tissue repository with
patient-signed informed consent. All tissue samples were assigned coded identifiers and relevant clinical information remained
concealed.
Mice
Female C57BL/6 mice (Charles River Laboratories) were bred in-house in the animal facility of the Barcelona Biomedical Research
Park under specific pathogen free (SPF) or conventional housing conditions. All mice were used at 8-12 weeks of age. Mice were
euthanized by cervical dislocation and animal procedures were approved by the Ethic Committee of the Barcelona Biomedical
Research Park and performed according to Spanish and European legislations.
METHOD DETAILS
Sample Processing
For the isolation of mononuclear cells from human intestinal samples, mucosa and submucosa were dissected from muscularis
externa and cut into 2-to-3-mm pieces. These pieces were first washed in calcium and magnesium-free Hanks’ balanced salt
solution (HBSS) before incubation at 37C for 20 min in HBSS containing 5mM Dithiothreitol (DTT) and 1 mM Ethylenediaminetetra-
acetic acid (EDTA). The tissue pieces were transferred into a falcon tube with 30ml of HBSS and shaken vigorously for 10 s twice. The
supernatant, containing the intra-epithelial lymphocytes fraction, was discarded. The remaining fraction was digested by incubation
for 40 min at 37C with stirring in a solution of HBSS containing 1 mg/ml collagenase IV (Thermo Fisher), 50ng/ml DNase (New
England Biolabs) and 0.5% human serum (Sigma). Lamina propria (LP) suspensions were passed through a 70-mm filter, washed,
and resuspended in RPMI 1640 medium (Thermo Fisher) with 10% fetal bovine serum (FBS). To isolate murine LP lymphocytes,
upon excision of PPs, small intestine (SI) and large intestine (LI) segments were opened longitudinally and cut into 5-mm pieces.
These pieces were subsequently processed following the same procedure used for human intestinal samples. Human splenocytes
and tonsillar mononuclear cells were obtained from fresh samples by enzymatic digestion of the tissue for 40min at 37C in a solution
of HBSS containing 1mg/ml collagenase IV (Thermo Fisher), 50ng/ml DNase (New England Biolabs) and 0.5%human serum (Sigma),
followed by separation on a Ficoll-Hypaque gradient (GE Healthcare). Peripheral blood mononuclear cells (PBMCs) were obtained
from heparinized blood samples by separation on Ficoll-Hypaque gradient.
Flow Cytometry
Cells were incubated at 4C with Fc-blocking reagent (Miltenyi Biotec) before the addition of the appropriate ‘cocktails’ of fluoro-
chrome-labeled monoclonal antibodies (mAbs). Dead cells were excluded through the use of 4’-6’-diamidine-20-phenylindole
(DAPI) (Sigma). Cells were acquired with LSR Fortessa (BD Biosciences) and data were further analyzed with FlowJo V10 software
(TreeStar).
Cell Sorting
For cell sorting, cell suspension were incubated at 4C with Fc-blocking reagent (Miltenyi Biotec) and stained for 30min with the
following monoclonal antibodies: anti-CD45 AF700 (clone: HI30), anti-CD19 PE-Cy7 (clone: HIB19), anti-CD38APC-Cy7 (clone:
HIT2), anti-CD10 PE (clone: HI10a), anti-IgM BV605 (clone: MHM-88) (all from Biolegend), anti-CD27 PerCpCy5.5 (clone: M-T271)
(BD Biosciences), and anti-IgD FITC (Southern). CD45+CD19+CD38dullCD10IgD2+ IgM+CD27 naive B cells, CD45+CD19+CD38dull
CD10IgD+IgM2+CD27+ MZ B cells, CD45+CD19+CD38intCD10+IgD-IgM+CD27+ GC-M, CD45+CD19+CD38dullCD10IgDIgM+
CD27+ ME-M B cells, CD45+CD19+ CD38dullCD10 IgDIgMCD27+ ME-SW B cells, CD45+CD19+CD38intCD10+IgDCD27+ GC
B cells, CD45+CD19+CD382+CD10IgDIgM+CD27+ PC-M and CD45+CD19+CD382+CD10 IgDIgM+CD27+ switched PC were
sorted with a FACSAria II (BD Biosciences) after exclusion of dead cells through DAPI staining. For sorting of FCRL4+ and FCRL4-
ME-M, anti-FCRL4 APC (clone: 413D12) was added to the ‘cocktails’. The purity of cells sorted this way was consistently > 95%.e4 Immunity 47, 118–134.e1–e8, July 18, 2017
Cell Cultures
Human sorted intestinal naive and ME-M B cells (1 3 105/well) were seeded in 96-well U-bottomed plates (Thermo Fisher) and
cultured for 6-7 days in complete RPMI 1640 medium (Thermo Fisher) supplemented with 10% FBS, penicillin and streptomycin
(10 U/ml) with or without 200 ng/ml megaCD40L (Enzo Life Science), 50 ng/ml IL-10 (Peprotech), 500 ng/ml IL-21 (Peprotech),
1 mg/ml CpG ODN-2006 (Invivogen), 500 ng/ml BAFF (Alexis) and 100 ng/ml Mega APRIL (Alexis).
Proliferation Assay
Cell proliferation was assessed with carboxyfluorescein succinimidyl ester (CFSE) using CellTrace CFSE Cell Proliferation Kit
(Thermo Fisher). Briefly, sorted lymphocytes were resuspended at 1x106 cell/ml in PBS supplemented with 5% FBS and incubated
with 1.25mM CFSE solution for 5 min at room temperature (RT). Stained cells were extensively washed and cultured for 6-7 days in
complete RPMI 1640 medium supplemented or not with specific stimuli. Cell division was assessed by measuring the decrease in
CFSE fluorescence via flow cytometry.
Generation of EBV-Transformed B Cells
For the generation of EBV-transformed B cell lines, sorted B cells were seeded at 5 3 104 cells/well in 96 U-bottom plates (Thermo
Fisher) in complete RPMI 1640 medium (Thermo Fisher) medium containing 2.5 mg/ml CpG ODN-2006 (Invivogen) and 30% super-
natant from the EBV-producing marmoset B cell line B95-8 (ECACC). Proliferating cells were maintained in culture for 2-3 weeks and
then frozen. Culture supernatants containing polyclonal immunoglobulins were stored at 80C.
ELISA
Total and antigen-specific IgM and IgA from culture supernatants were detected by home-made ELISA. Briefly, 96 well ELISA plates
(Thermo Fisher) were coated over night with goat anti-human Ig-UNLB (Southern Biotech) at 1ug/ml. To measure Ab-reactivity to
specific antigens, ELISA plates were coated with either b-D-glucan (50 mg/ml; Sigma) or capsular polysaccharides (1 mg/ml;
ATCC), Gal-a1,3-gal-HSA (3 atom spacer) (10 mg/ml; Dextra Laboratories), laminarin (50 mg/ml, Sigma) or L-a-Phosphatidylcholine
(0.5 mg/ml; Bioresearch Technologies). For total Ig, serial dilutions of cell culture supernatants were added for 2 hr. for antigen-spe-
cific Ig, supernatants were used at 20 mg/ml Ig concentration and three 1:10 dilutions in PBS. All ELISAs were developed using HRP-
labeled goat anti-human IgM (0.2 mg/ml; cappel) or IgA Fc Ab (0.25 mg/ml; Southern Biotech) and TMB substrate reagent set (BD
Bioscience). OD450wasmeasured and Ab-reactivity was calculated after subtraction of background (OD450 of culture supernatants
on PBS coated plates).
Immunofluorescence Analysis
Formalin-fixed paraffin-embedded human tissue sections 3-mm in thickness were treated in xylene, a decreasing alcohol gradient
and distilled water to achieve de-waxing and rehydration of the tissue. Heat induced epitope retrieval was performed for 15 min
in citrate buffer (pH 6) or Tris-EDTA buffer (pH 9). After epitope retrieval, tissue sections were permeabilized with 0.2% Triton
X-100 in PBS, blocked with 5% bovine serum albumin and 5% Fc receptor blocking (Miltenyi Biotec) and stained with various
combinations of antibodies to specific antigens. Biotinylated antibodies were detected with streptavidin–Alexa Fluor conjugates.
Nuclear DNA was visualized with DAPI and coverslips applied with FluorSave reagent (Merck Millipore). Images were acquired either
with a Leica TCS SP5Upright confocal microscope (Leica) or a Nikon Eclipse Ni-Emicroscope (Nikon) andwere further analyzedwith
ImageJ software.
Giemsa Staining
Cytospins were performed from sorted intestinal population at 800 rpm for 5 min using a Cytospin 4 apparatus (Thermo Fisher).
Approximately 5,000 cells per subset were dried overnight on albumin-coated slides and stained with Giemsa Stain Kit (Jenner-
Wright) (Agilent).
RNA Extraction and Reverse Transcription
Total cellular RNA was isolated with the RNeasy Micro kit (QIAGEN) by following the manufacturer’s protocol. Approximately 2 ng of
RNA with were reversed transcribed into cDNA using TaqMan Reverse Transcription Reagents and Random hexamers (Thermo
Fisher).
Quantitative Real Time and Standard PCR
Quantitative real time PCR (qRT-PCR) were performed in 384-well plates containing Power Sybr Green PCR Master Mix (Thermo
Fisher) and specific primer pairs (Table S1) and analyzed on QuantStudio 12K Flex Real-Time PCR System (Thermo Fisher).
Gene expression was normalized to that of the gene encoding b-actin (ACTB) for each sample and results were presented as relative
expression (RE) compared to naive B cells. For the analysis of germline Im-Cm, Ia-Ca1 and Ia-Ca2 transcripts, PCRs were carried out
using specific primers (Table S2) in a 50 mLPCR volumewith AmpliTaqGold PCRMastermix (Thermo Fisher). Nested PCR analysis of
Ia-Cm circle transcript was carried out using two sets of specific primer pairs (Table S2) and the following cycling conditions. In the
first PCR round, external primers were used in an initial denaturing step at 95C for 9min followed by 30 cycles comprised of 94C for
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for 9 min followed by 25 cycles comprised of 94C for 30 s, 60C for 1 min and 72C for 10 min. PCR products were subjected to
Sanger sequencing for confirmation.
KREC Assay
Genomic DNA was isolated from sorted B cell subsets with QIAamp DNAMini Kit (QIAGEN). The replication history of B cell subsets
was determined using the k-deleting recombination excision circle (KREC) assay as described previously (van Zelm et al., 2007). This
assay is based on a quantification of coding joints and signal joints of an Igk-deleting rearrangement (intron RSS-Kde) by qRT-PCR.
The DCT between the signal joint and the coding joint exactly represents the number of cell divisions a B cell has undergone. The
previously established control cell line U698 DB01 (van Zelm et al., 2007) contains 1 coding and 1 signal joint per genome and
was used to correct for minor differences in efficiency of both real-time quantitative-PCR assays.
Global Transcriptome Analysis
Total cellular RNA was isolated with the RNeasy Micro kit (QIAGEN) from sorted B cell subsets by following the manufacturer’s
protocol. RNA integrity was assessed using Agilent 2100 Bioanalyzer (Agilent). Only samples with high integrity (RNA integrity number
R 7) were used for transcriptome analysis. Amplification, labeling and hybridizations were performed according to protocol
Ovation Pico WTA System V2 and Encore Biotin Module (NuGEN) and then hybridized to GeneChip Human Gene 2.0 ST Array
(Affymetrix) in a GeneChip Hybridization Oven 640. Washing and scanning were performed using the Expression Wash, Stain and
Scan Kit (Affymetrix) and the Affymetrix GeneChip System including GeneChip Fluidics Station 450 and GeneChip Scanner 3000
7G. After quality control, raw data were background corrected, quantile-normalized and summarized to a gene-level using the robust
multi-chip average (RMA) system. For the detection of differentially expressed genes, a linear model was fitted to the data and
empirical Bayes moderated statistics were calculated using the limma package from Bioconductor (Wettenhall and Smyth, 2004).
Adjustment of p values was performed by the determination of false discovery rates (FDR) using the Benjamini-Hochberg procedure.
Genes with an adjusted p value less than 0.05 and with an absolute fold change value above 1.5 were selected as significant. Spear-
man’s rank correlation was used to study correlation between normalized gene expressions of the different comparisons. Analyses
were performed with R and standard packages. Comparison Upstream Regulator Analysis with Ingenuity Pathway Analysis (Ingenu-
ity Systems, www.ingenuity.com) and GSEA from the Molecular Signature Database (MSigDB) (Subramanian et al., 2005) were used
to identify similarities and differences among samples.
Next Generation Sequencing of Ig Gene Repertoires
Aliquots of cDNA products from sorted B cells (Table S3) were mixed with high performance liquid chromatography-purified primers
specific for VH1-VH6 framework region 1 (50 nM) and primers specific for Ca or Cm (250 nM) containing corresponding Illumina
Nextera sequencing tags (Table S4) in a PCR volume of 25 mL (4 mL template cDNA) with High Fidelity Platinum PCR Supermix
(Thermo Fisher). Amplification was performed using the following conditions. An initial step of 95C for 5 min was followed by
35 cycles including 95C for 30 s, 58C for 30 s, and 72C for 30 s, supplemented with a final extension step of 72C for 5 min.
Products were purified with miniElute PCR purification Kit (QIAGEN) and Nextera indices were added via PCRwith the following con-
ditions: 72C for 3min, 98C for 30 s, 5 cycles of 98C for 10 s, 63C for 30 s, and 72C for 3min. Ampure XP beads (Beckman Coulter
Genomics) were used for purification of the PCR products, which were subsequently pooled and denatured. Single-strand products
were paired-end sequenced on a MiSeq (Illumina) with the 500 Cycle v2 Kit (2 3 250 bp). In total, 4,898,226 IGHV gene sequences
from four donors were obtained through next generation sequencing (Table S3). Paired-end raw sequencing reads were processed
into donor-specific Ig gene sequences and grouped in clonal families using a bioinformatics pipeline based on pRESTO, IgBLAST
and Change-O (Gupta et al., 2015; Vander Heiden et al., 2014; Ye et al., 2013). First, raw reads with a Phred score lower than 20
were filtered out, and primers for CH and VH genes were masked. Next, corresponding paired-end reads were aligned and merged
together (minimum overlap of 6 nucleotides) and annotated with donor, cell type and isotype origin. Finally, donor-specific Ig subsets
were combined (prior to VDJ annotation) to estimate donor-specific clonal families. VDJ calling and assignment were performed us-
ing the default parameters for IgBLAST and querying the latest downloaded human IGH IMGT database from February 2016. Donor-
specific clonal groups were inferred using a distance-based clustering method implemented in Change-O. Sequences with the same
VH and JH annotation, identical H-CDR3 region length and Hamming distance higher than 85% were considered to belong to the
same clonal group or family. Finally, germline sequences for each clone were reconstructed using the annotated VDJ information
as implemented in Change-O. Donor-specific clonal groups were represented through RCircos plots to visualize the relationships
between B cell subsets at clonal level. Morisita-Horn Index estimates were calculated using the divo R package. In both analyses,
a rarefied sample of 10,000 clones per subset was used to account for possible sample size biases between donors, tissues and cell
types. MHI bootstrap estimates were calculated by resampling 1,000 times a subsample of 10,000 clones for each tissue, cell type
and donor. VH and JH gene usage was estimated for each donor and B cell subset, with bars representing average values among
donors. SHM levels were estimated by averaging the number ofmutations compared to the inferred germline sequence of each clone
belonging to a given B cell subset and donor. Donor-specific clonally related B cell lineage trees were reconstructed and plotted
using IgTree Software (Barak et al., 2008).e6 Immunity 47, 118–134.e1–e8, July 18, 2017
Mucus Collection and Processing
Mucus was obtained by scrapping off the epithelial surface of macroscopically unaffected fresh tissue samples from terminal ileum
and ascending colon of patients undergoing right hemicolectomy. Intestinal contents frommurine SI and LI segments were removed
by running forceps along a given intestinal segment and placed in a 1.5mL Eppendorf tube on ice. Aliquots of microbial samples from
mucus or intestinal contents were weighed and resuspended at 0.1 mg/mL in PBS with protease inhibitors from SIGMAFAST Prote-
ase Inhibitor Tablets (Sigma). Samples were homogenized by vigorously vortexing for 5 min and then centrifuged at 400 g for 5min to
pellet large debris. The supernatant was filtered through a sterile 70 mm cell strainer and centrifuged at 8000 g for 5 min to pellet
microbes. At this stage, supernatants were saved and frozen at 80C for the analysis of free SIgM and Sig and microbial pellets
were used for bacterial flow cytometry and FACSorting.
Bacterial Flow Cytometry and FACSorting
To measure endogenous SIgM and SIgA bound to intestinal bacteria, microbial pellets were resuspended in PBS 5% FBS and incu-
bated for 30 min on ice with the following combination of antibodies: anti-human IgM APC (clone: SA-DA4) (Southern Biotech) and
anti-human IgA PE (Miltenyi Biotec). Finally, bacterial samples were washed and resuspended in PBS with SYTO BC (Thermo Fisher)
for 15 min on ice to perform FCM analysis. To measure reactivity of IgM from EBV-transformed B cells against intestinal microbiota,
endogenous bacteria-bound SIgs were stripped following incubation for 3 min in an acidic sodium citrate buffer (40 mM sodium
citrate and 140 mMNaCl, pH 3.0). Then, microbes were quickly spun down to remove the buffer and PBS was added for pH neutral-
ization. These samples were incubated with supernatants from EBV-transformed B cells (at 50 mg/ml total IgM) for 30 min on ice.
After washing, microbial pellets were resuspended in MACS 5% FBS and incubated for 30 min on ice with anti-human IgM APC
(clone: SA-DA4) (Southern Biotech). Finally, samples were washed and resuspended in PBS with SYTO BC (Thermo Fisher) for
15 min on ice for FCM analysis. To measure reactivity of IgM from EBV-transformed B cells against specific bacterial species
(Escherichia coli, Bacillus cereus, Bacteroides vulgatus, Bacteroides fragilis, Bacteroides thetaiotaomicron-all from ATCC and
Ruthenibacterium lactatiformans and Roseburia intestinalis from DSMZ), 105 to 106 heat inactivated bacteria (65C for 20 min)
were incubated for 15 min at RT with graded amounts of IgM from EBV-transformed ME-M B cell lines (from 0.18 to 15 mg/ml total
IgM). After washing, microbial pellets were resuspended in PBS and incubated for 15min with anti-human IgM APC (clone: SA-DA4)
(Southern Biotech) in the presence of SYTO BC (Thermo Fisher). Contamination was minimized by passing all buffers and media
through sterile 0.22-mm filters before use. In all settings, bacterial FCM was performed using a FORTESSA Cytometer (BD Bio-
sceince) with low forward scatter (FSC) and side scatter (SSC) thresholds to allow bacterial detection. FSC and SSC were set to
a Log scale and samples were gated FSC+SSC+SYTO BC+ and then assessed for IgA and IgM staining. Microbial samples were
sorted using a FACSAria II (BD Biosciences) instrument. Threshold settings were set to the minimal allowable voltage for SSC
and 50,000 events were collected from SIgASIgM, SIgA+SIgM or SIgA+SIgM+ fractions gates as shown in Figure 7A. Each frac-
tion (typically 50 mL) was stored at20C before performing PCR and sequencing of bacterial 16S rRNA genes. Multiple precautions
were taken to minimize potential contamination of FACSorted fractions, including collecting samples from the flow cytometer droplet
stream (sheath fluid) immediately before each sorting to allow assessment of any potential contaminants in fluid lines.
Bacterial 16S rRNA Gene Analysis
DNA was extracted from unsorted mucus samples using PureLink Microbiome DNA Purification Kit (Thermo Fisher) following the
manufacturer’s instructions and amplicons of V3-V4 regions of 16S rRNA genes were generated as described below. 16S rRNA
amplicons from FACSorted bacteria were generated by adding 2.5 mL of each bacterial fraction directly to Platinum PCR SuperMix
High Fidelity (Thermo Fisher) containing PCR primers that target 16S V3 and V4 region (Table S4) in triplicate 20cml reactions. 16S
rRNA analysis was performed on samples collected from the flow cytometer droplet stream before every sort (sheath fluid), which
permitted the identification of sequences that did not originate from the sorted sample. The following PCR conditions were used:
an initial denaturation step at 95cC for 10cmin was followed by 35 cycles that included 95cC for 30csec, 55cC for 30csec, and
72C for 30 s, with an ending step of 72cC for 5cmin. Triplicate reactions were pooled and subjected to 1% agarose gel electro-
phoresis to verify the presence of a PCR product (these gels also contained negative control reactions). Pooled amplicons were
purified with AMPure XP magnetic beads (Agencourt) and subjected to multiplexed sequencing (paired-end 250 nucleotide reads)
on aMiSeq instrument (Illumina) with the 500 Cycle V2 Kit (23 250 bp). Paired-end reads were filtered (Phred > 19) andmerged using
the fastq-join algorithm. De-multiplexed reads were clustered into operational taxonomic units (OTUs) with a 97% identity sequence
using the gg_13_5 release from Greengenes database as well as the default open reference QUIIME pipeline for Ilumina reads
(Caporaso et al., 2010). Similar to FACSorted fractions, sheath fluid samples were sequenced and processed to identify putative
contaminant OTUs. A comparison against ‘‘high-biomass’’ samples (mucus) was performed to pick the most frequent contaminant
OTU found in the sheath fluid but not in ‘‘high-biomass’’ samples. This reference contaminant OTU was then used to proportionally
remove all the other contaminant OTUs found in either sheath fluid or FACSorted samples. Finally, an ‘abundance-filtered dataset’
was generated by selecting OTUs that were detected at > 0.1% relative abundance in each sample. This OTU table was then
rarefied to the minimum sample’s depth (27529 reads). Rarefied alpha diversity plots for Shannon Index and Phylogenetic Diversity
(PD_whole_tree) were generated using default QIIME scripts. A log-transformed Enrichment Index (EI) was calculated for each OTU
and sample according to the formula shown in Figure 7F. Only OTUs present in input samples at least 3 times and at a frequency
higher than 0.1% were used to build the final EI distributions. The heatmap plot was generated using mean values from EI distribu-
tions. OTUs and fractions were then grouped through a hierarchical clustering algorithm.Immunity 47, 118–134.e1–e8, July 18, 2017 e7
Quantification and Statistical Analysis
Differences between means from independent groups were assessed using Prism 5.03 software (GraphPad) and R studio. For com-
parison of two groups, P values were determined by unpaired two-tailed Student’s t test, unless otherwise indicated. For comparison
of more than two groups, significant values were calculates via one-way ANOVA with Tukey’s post hoc test. p values < 0.05 were
considered significant. P values are indicated on plots and in figure legends. (* p < 0.05, ** p < 0.01, *** p < 0.001).
DATA AND SOFTWARE AVAILABILITY
The Gene Expression Omnibus accession number for the global gene transcriptional analysis reported in this paper is GEO:
GSE89282. Sequencing data are publicly available under BioProject accession number BioProject: PRJNA355402.e8 Immunity 47, 118–134.e1–e8, July 18, 2017
